Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement Safe and pragmatic use of SGLT2 inhibitors in type 2 diabetes mellitus: SAFES consensus statement EXECUTIVE SUMMARY: SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2i) JPMA Gestational diabetes guidelines
